Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London
"Blumenthal, Uri - 0553 - MITLL" <uri@ll.mit.edu> Mon, 15 August 2022 23:04 UTC
Return-Path: <prvs=6226df957b=uri@ll.mit.edu>
X-Original-To: 114attendees@ietfa.amsl.com
Delivered-To: 114attendees@ietfa.amsl.com
Received: from localhost (localhost [127.0.0.1]) by ietfa.amsl.com (Postfix) with ESMTP id 598E1C14F74D for <114attendees@ietfa.amsl.com>; Mon, 15 Aug 2022 16:04:18 -0700 (PDT)
X-Virus-Scanned: amavisd-new at amsl.com
X-Spam-Flag: NO
X-Spam-Score: -1.903
X-Spam-Level:
X-Spam-Status: No, score=-1.903 tagged_above=-999 required=5 tests=[BAYES_00=-1.9, HTML_MESSAGE=0.001, MIME_QP_LONG_LINE=0.001, SPF_HELO_NONE=0.001, SPF_NONE=0.001, T_SCC_BODY_TEXT_LINE=-0.01, URIBL_BLOCKED=0.001, URIBL_DBL_BLOCKED_OPENDNS=0.001, URIBL_ZEN_BLOCKED_OPENDNS=0.001] autolearn=ham autolearn_force=no
Received: from mail.ietf.org ([50.223.129.194]) by localhost (ietfa.amsl.com [127.0.0.1]) (amavisd-new, port 10024) with ESMTP id lYiQR6ZPewX8 for <114attendees@ietfa.amsl.com>; Mon, 15 Aug 2022 16:04:14 -0700 (PDT)
Received: from MX3.LL.MIT.EDU (mx3.ll.mit.edu [129.55.12.52]) (using TLSv1.2 with cipher ECDHE-RSA-AES256-GCM-SHA384 (256/256 bits)) (No client certificate requested) by ietfa.amsl.com (Postfix) with ESMTPS id 07ADCC14F726 for <114attendees@ietf.org>; Mon, 15 Aug 2022 16:04:13 -0700 (PDT)
Received: from LLEX2019-1.mitll.ad.local (llex2019-1.llan.ll.mit.edu [172.25.4.123]) by MX3.LL.MIT.EDU (8.17.1.5/8.17.1.5) with ESMTPS id 27FN3tKQ211451 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384 bits=256 verify=FAIL); Mon, 15 Aug 2022 19:03:55 -0400
ARC-Seal: i=1; a=rsa-sha256; s=arcselector5401; d=microsoft.com; cv=none; b=ZZVMtv2v6PUWvSdwM+UhHOSk6dKmEBRQaBum6pAncBTSi3Vh7m+1jqVJZnPcRfQwSL7Q8/6Ie7IYMSABFH3tM3jNm5sJZ8gEtjEOCGCWciGSwNFKY6GdR3XvUOJ7Y3LvFb39IP+Fm38fOJUXcmm9+Hr6s2g1Ls70J2//FP/F8ipkPKQjizqlMmwfp6M5RiYESwPVUzZ9xuQMv7n62PonG/D/Pz6l8ee7Z37QoYTqH+itJdQ3nP/8o9xEyOJmmKP3B/AybE+5b8LRwKsTBm7tPrOrQrMWOe4l3+AZ99UVgSRO7zR9q/hrE4FMZYlc/hFIFzsySGOHlMD/V0tkx8hq9g==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector5401; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=1HBRnLqWEb80WHSQd6+dQ49U39k1qWzBz6GPi0M4IBI=; b=T2m3+f60aARPukoVBqePOVQ5KdMiYvGQt2SHTi5GbhbAaSxRDCJvqTBvfUXEk2CrJTd7AQxdIH29dnI9adUdke1LMFAHBjMxdxKP14c4a6janUHlQHQlfmHQBVO0LEr9nyQpkcAAwKJ42ZPTInATbvCkXrREuqZJAwx016JDmwYfopRetjrTyGLaezDYfkaSN4a2y+qVAogbq97JhL1ZVlN6fIEjWxquY2BjiTxhv0ubqLH4Thg6HvT+Y1QBUg7KQjnhGl8C1ZFEav8Dkd/prKtkbMiy4f46rg5v1IdRf2pHeupZnppnOy3qjva7rQwGqXvS2XQP8AvDZ5wQoJDOxA==
ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=ll.mit.edu; dmarc=pass action=none header.from=ll.mit.edu; dkim=pass header.d=ll.mit.edu; arc=none
From: "Blumenthal, Uri - 0553 - MITLL" <uri@ll.mit.edu>
To: "114attendees@ietf.org" <114attendees@ietf.org>
CC: Margaret Cullen <mrcullen42@gmail.com>
Thread-Topic: [114attendees] [114all] Consultation on COVID management for IETF 115 London
Thread-Index: AQHYrk7EUefS13iKqE++c8XRj00c6K2rocUAgAAVmoCAAAHWgIAABuoAgAABAQCAAAZBgIAAC7kAgASN2QCAADD4AIAAAYkA///DdwA=
Date: Mon, 15 Aug 2022 23:03:57 +0000
Message-ID: <C5E1B1C0-9880-40A9-845F-31290B01415F@ll.mit.edu>
References: <4B348C11-79CE-4E7E-9DFD-B5CE79224767@ietf.org> <2F1594AF-4729-4908-918E-CD2151639E23@samuelsmith.org> <9c06d39e-0a03-916f-89e3-eff9ed2231bf@petit-huguenin.org> <CF6F11B2-6E3D-45FD-B520-29FE7DA52658@live555.com> <df828417-9229-4f67-93bf-9de9202e1950@petit-huguenin.org> <LO0P123MB660168369A86618248E627B5A9679@LO0P123MB6601.GBRP123.PROD.OUTLOOK.COM> <CAMOjQcFkuBWOGPCwP=UFbodA15R79COvncHw-nm1YmFFoL1N+w@mail.gmail.com> <6aa68882-60bb-4a7c-ad84-51c58f7bd78a@evequefou.be> <B53FD62C-6AFD-4048-823E-F723A14C207B@gmail.com> <9e5b5853-2f5b-e5ab-19da-562f8a099b7b@joelhalpern.com> <CAPt1N1kiuq6PnQUkKbqekdhoJ-s8EXiUAOyYKt3ekZ94vNokyg@mail.gmail.com>
In-Reply-To: <CAPt1N1kiuq6PnQUkKbqekdhoJ-s8EXiUAOyYKt3ekZ94vNokyg@mail.gmail.com>
Accept-Language: en-US
Content-Language: en-US
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator:
user-agent: Microsoft-MacOutlook/16.63.22070801
x-ms-publictraffictype: Email
x-ms-office365-filtering-correlation-id: cba87201-5817-4aaf-ac5c-08da7f126f14
x-ms-traffictypediagnostic: BN0P110MB0949:EE_
x-ms-exchange-senderadcheck: 1
x-microsoft-antispam: BCL:0;
x-microsoft-antispam-message-info: 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
x-forefront-antispam-report: CIP:255.255.255.255; CTRY:; LANG:en; SCL:1; SRV:; IPV:NLI; SFV:NSPM; H:BN0P110MB1419.NAMP110.PROD.OUTLOOK.COM; PTR:; CAT:NONE; SFS:(13230016)(366004)(6916009)(76116006)(6486002)(966005)(186003)(38100700002)(86362001)(2906002)(2616005)(7066003)(66476007)(4326008)(66556008)(122000001)(8676002)(66446008)(66946007)(64756008)(45080400002)(83380400001)(166002)(8936002)(99936003)(5660300002)(498600001)(53546011)(26005)(75432002)(6512007)(38070700005)(71200400001)(33656002)(6506007)(45980500001); DIR:OUT; SFP:1102;
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0: AQ7/g1m4rULWqbasjVMURZE4eh5tlubMnTFa8hUSUqHQJzlVlAqosdkSdAcLoezcHTOdX5MVQQ6+OpIjwxyWAz4N4wa4QS+j4YuqEyT74vtjFk9AuHN4tH0TsKAjqDmK5mWvUQd59W2eWacqrCCHHwVAy9rKwda2/Vg8BNQhm5Y1K08bJvmwZuQup3E4ZZX3GlXNbNfXoYRLPMRMXNgoGcOO5U6xA8ROVXM58CSZGu55StNfpIbZDiskYluQ5n3EHXsDNTpn4hjFbGTL8Z4C+PkDwE06YhmgpsmhbXhGOGD3ivtjyY0XQ/67JAB1Jpon0TgPfOtLNGjxwutkFZC+eMaVvqIHuzs0iZmRYeCqInd14XRozX8uGPDZCjCvEYa4zsN9snE9yStpjtZajjRqKsbJWhqNZ1NZTABNDhJO3G8=
Content-Type: multipart/signed; protocol="application/pkcs7-signature"; micalg="sha256"; boundary="B_3743435036_1135526960"
MIME-Version: 1.0
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: BN0P110MB1419.NAMP110.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: cba87201-5817-4aaf-ac5c-08da7f126f14
X-MS-Exchange-CrossTenant-originalarrivaltime: 15 Aug 2022 23:03:57.5486 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 83d1efe3-698e-4819-911b-0a8fbe79d01c
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BN0P110MB0949
X-Proofpoint-GUID: 4YxklkpbimTa1nFMXA8zUYnTWgJT1ubJ
X-Proofpoint-ORIG-GUID: 4YxklkpbimTa1nFMXA8zUYnTWgJT1ubJ
X-Proofpoint-Virus-Version: vendor=baseguard engine=ICAP:2.0.205,Aquarius:18.0.883,Hydra:6.0.517,FMLib:17.11.122.1 definitions=2022-08-15_08,2022-08-15_01,2022-06-22_01
X-Proofpoint-Spam-Details: rule=notspam policy=default score=0 suspectscore=0 mlxscore=0 malwarescore=0 mlxlogscore=999 bulkscore=0 spamscore=0 phishscore=0 adultscore=0 classifier=spam adjust=0 reason=mlx scancount=1 engine=8.12.0-2207270000 definitions=main-2208150089
Archived-At: <https://mailarchive.ietf.org/arch/msg/114attendees/XH6Q-gZPGWyjYUvxOmMPBw470So>
Subject: Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London
X-BeenThere: 114attendees@ietf.org
X-Mailman-Version: 2.1.39
Precedence: list
List-Id: Mailing list for IETF 114 attendees <114attendees.ietf.org>
List-Unsubscribe: <https://www.ietf.org/mailman/options/114attendees>, <mailto:114attendees-request@ietf.org?subject=unsubscribe>
List-Archive: <https://mailarchive.ietf.org/arch/browse/114attendees/>
List-Post: <mailto:114attendees@ietf.org>
List-Help: <mailto:114attendees-request@ietf.org?subject=help>
List-Subscribe: <https://www.ietf.org/mailman/listinfo/114attendees>, <mailto:114attendees-request@ietf.org?subject=subscribe>
X-List-Received-Date: Mon, 15 Aug 2022 23:04:18 -0000
Very good reasons listed, thank you. My feedback: I would factor the meeting policy when considering whether to attend in-person, but at least at the 114th IETF I had overwhelming reasons to participate remotely only, and expect those reasons to stay valid (for me) for at least the next several meetings. Thus, no change in IETF meeting policy would’ve affected my decision to participate remotely, either this time, or for a few following meetings. Thanks! -- V/R, Uri There are two ways to design a system. One is to make it so simple there are obviously no deficiencies. The other is to make it so complex there are no obvious deficiencies. - C. A. R. Hoare From: 114attendees <114attendees-bounces@ietf.org> on behalf of Ted Lemon <mellon@fugue.com> Date: Monday, August 15, 2022 at 18:41 To: Joel Halpern <jmh@joelhalpern.com> Cc: "114attendees@ietf.org" <114attendees@ietf.org>, Margaret Cullen <mrcullen42@gmail.com> Subject: Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London It’s also worth noting that when I am at home, I have a great deal of control over the risks I take. When I’m at IETF, I’m at the mercy of the IETF’s mitigation strategy. For some, that strategy will seem like more than what they do at home. For others, perhaps less. A better question might be, how many people who would attend the meeting were the policy different, as compared to how many attend it with the current policy. If we think in person attendance is beneficial, this is really the only question that matters. If we don’t think it’s important, we should go back to online-only. On Mon, Aug 15, 2022 at 18:35 Joel Halpern <jmh@joelhalpern.com> wrote: That comparison seems a reasonable question. I am not a statistician or an epidemiologist, so I may have gotten the comparatives wrong. Looking at the data for Pennsylvania as reported by the New York Times, they report for a week 25 cases per 100,000 people. The highest County reports 60 cases per 100,000. Rounding our rate to 2.5 percent, and our attendance to 500 just to keep things simple, our experience would be a rate of 500 cases per 100,000 people per week. So yes, attending the IETF meeting does seem to be related to a significant increase in risk even with the rules we had in place. If I have misunderstood the data, I hope someone who knows more will correct me. Yours, Joel On 8/15/2022 3:39 PM, Margaret Cullen wrote: Do we have any idea how the percentage of IETF attendees infected with COVID during the IETF week compares to the percentage who would have been infected if they stayed home? Margaret On Aug 12, 2022, at 6:07 PM, Mike Bishop <mbishop@evequefou.be> wrote: And this, in my opinion, is the primary goal. It is a useful secondary goal to minimize excess exposure to CoVID among participants relative to the exposure we would have had without an IETF meeting. But the primary goal of the IETF's precautions is to ensure enough attendees are willing to take the risk of coming to ensure a successful meeting. The recommendations as stated strike an excellent balance between comforting the nervous, reducing transmission where possible, and minimizing burden on attendees. Sent from Nine From: Eric Orth <ericorth=40google.com@dmarc.ietf.org> Sent: Friday, August 12, 2022 2:25 PM To: 114attendees@ietf.org Subject: Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London Scientifically beneficial or not (I'm not going to get into that debate), the proposals Jay has outlined would go a long way towards making me feel comfortable attending an international conference, so I support those proposals. On Fri, Aug 12, 2022 at 5:03 PM Yaron Sheffer <yaronf.ietf@gmail.com> wrote: +1 to Marc. From: 114attendees <114attendees-bounces@ietf.org> on behalf of Marc Petit-Huguenin <marc@petit-huguenin.org> Date: Saturday, 13 August 2022 at 0:00 To: Ross Finlayson <finlayson@live555.com>, 114attendees@ietf.org <114attendees@ietf.org> Subject: Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London We should do better than that. Except for the couple of first days of IETF 114, the policy was stronger than what was recommended locally and that's the reason why I will go to London. FTR I support everything Jay proposed. On 8/12/22 13:34, Ross Finlayson wrote: > I think that the IETF (and IETFers) should avoid straying into areas outside their areas of expertise, and just follow whatever policy is recommended by the locality where each meeting is held. > > Ross. > -- Marc Petit-Huguenin Email: marc@petit-huguenin.org Blog: https://marc.petit-huguenin.org Profile: https://www.linkedin.com/in/petithug -- 114attendees mailing list 114attendees@ietf.org https://www.ietf.org/mailman/listinfo/114attendees -- 114attendees mailing list 114attendees@ietf.org https://www.ietf.org/mailman/listinfo/114attendees -- 114attendees mailing list 114attendees@ietf.org https://www.ietf.org/mailman/listinfo/114attendees
- Re: [114attendees] [114all] Consultation on COVID… ProSapien Sam Smith
- Re: [114attendees] [114all] Consultation on COVID… Personal Sam Smith
- Re: [114attendees] [114all] Consultation on COVID… Marc Petit-Huguenin
- Re: [114attendees] [114all] Consultation on COVID… Ross Finlayson
- Re: [114attendees] [114all] Consultation on COVID… Phillip Hallam-Baker
- Re: [114attendees] [114all] Consultation on COVID… Marc Petit-Huguenin
- Re: [114attendees] [114all] Consultation on COVID… Yaron Sheffer
- Re: [114attendees] [114all] Consultation on COVID… Eric Orth
- Re: [114attendees] [114all] Consultation on COVID… Dean Bogdanovic
- Re: [114attendees] [114all] Consultation on COVID… Sorin Faibish
- Re: [114attendees] [114all] Consultation on COVID… Tony Li
- Re: [114attendees] [114all] Consultation on COVID… Marc Petit-Huguenin
- Re: [114attendees] [114all] Consultation on COVID… Mike Bishop
- Re: [114attendees] [114all] Consultation on COVID… Randy Bush
- Re: [114attendees] [114all] Consultation on COVID… Smith, Andy
- Re: [114attendees] [114all] Consultation on COVID… Les Ginsberg (ginsberg)
- Re: [114attendees] [114all] Consultation on COVID… Christian Huitema
- Re: [114attendees] [114all] Consultation on COVID… Samuel Weiler
- Re: [114attendees] [114all] Consultation on COVID… Wes Hardaker
- Re: [114attendees] [114all] Consultation on COVID… Phillip Hallam-Baker
- Re: [114attendees] [114all] Consultation on COVID… Jordi Palet Martínez
- Re: [114attendees] [114all] Consultation on COVID… Toerless Eckert
- Re: [114attendees] [114all] Consultation on COVID… Toerless Eckert
- Re: [114attendees] [**EXTERNAL**] Re: [114all] Co… Shah, Himanshu
- Re: [114attendees] [114all] Consultation on COVID… John Levine
- Re: [114attendees] [114all] Consultation on COVID… Phillip Hallam-Baker
- Re: [114attendees] [114all] Consultation on COVID… Jari Arkko
- Re: [114attendees] [114all] Consultation on COVID… Margaret Cullen
- Re: [114attendees] [114all] Consultation on COVID… Joel Halpern
- Re: [114attendees] [114all] Consultation on COVID… Ted Lemon
- Re: [114attendees] [114all] Consultation on COVID… Joel Halpern
- Re: [114attendees] [114all] Consultation on COVID… Jordi Palet Martínez
- Re: [114attendees] [114all] Consultation on COVID… Blumenthal, Uri - 0553 - MITLL
- Re: [114attendees] [114all] Consultation on COVID… John Levine
- Re: [114attendees] [114all] Consultation on COVID… Behcet Sarikaya
- Re: [114attendees] [114all] Consultation on COVID… Marco Davids (SIDN)
- Re: [114attendees] [114all] Consultation on COVID… Ted Lemon
- Re: [114attendees] [114all] Consultation on COVID… Marco Davids
- Re: [114attendees] [114all] Consultation on COVID… Salz, Rich
- Re: [114attendees] [114all] Consultation on COVID… Personal Sam Smith
- Re: [114attendees] [114all] Consultation on COVID… Jeff Haas
- Re: [114attendees] [114all] Consultation on COVID… Personal Sam Smith
- Re: [114attendees] [114all] Consultation on COVID… Jeff Haas
- Re: [114attendees] [114all] Consultation on COVID… Sebastian Moeller
- Re: [114attendees] [114all] Consultation on COVID… Ted Lemon
- Re: [114attendees] [114all] Consultation on COVID… Personal Sam Smith
- Re: [114attendees] [114all] Consultation on COVID… Jeff Haas
- Re: [114attendees] [114all] Consultation on COVID… Personal Sam Smith